Lithium augmentation is associated with further improvement in patients with treatment-resistant depression

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1261, 2000-01, pp. : 18-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quetiapine augmentation in treatment-resistant depression: a naturalistic study

By Šagud Marina Mihaljević-Peleš Alma Mück-Šeler Dorotea Jakovljević Miro Pivac Nela

Psychopharmacology, Vol. 187, Iss. 4, 2006-09 ,pp. : 511-514

Springer Publishing Company

Access to resources Recommend Favorite

Debate continues over the use of combination antidepressants in patients with treatment-resistant depression

By Alderman Christopher P.

Drugs & Therapy Perspectives, Vol. 28, Iss. 6, 2012-06 ,pp. : 23-25

Adis International

Access to resources Recommend Favorite

Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

By Singh Jaskaran Zarate Carlos Krystal Andrew

Psychopharmacology, Vol. 173, Iss. 1-2, 2004-04 ,pp. : 227-228

Springer Publishing Company

Access to resources Recommend Favorite

Lamotrigine In Adolescent Treatment–Resistant Depression

Child and Adolescent Psychopharmacology News, Vol. 11, Iss. 2, 2006-05 ,pp. : 1-10

Guilford Publications Inc

Access to resources Recommend Favorite

Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence

By Mathew Sanjay J. Shah Asim

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 189-204

Adis International

Access to resources Recommend Favorite